Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter

Cronin, Therese; Vandenberghe, Luk H; Hantz, Péter; Juttner, Josephine; Reimann, Andreas; Kacsó, Ágota–Enikő; Huckfeldt, Rachel M; Busskamp, Volker; Kohler, Hubertus; Lagali, Pamela S; Roska, Botond; Bennett, Jean

doi:10.15252/emmm.201404077

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter

Published Date:

Aug 04 2014

Publisher's site:

http://dx.doi.org/10.15252/emmm.201404077 New Site Icon

Source:

EMBO Mol Med. 2014; 6(9):1175-1190.

[PDF-1.56 MB]

Details:

Personal Authors:

Cronin, Therese ; Vandenberghe, Luk H ; Hantz, Péter ; Juttner, Josephine ; Reimann, Andreas ; ... More ▼

Keywords:

[+]

Pubmed ID:

25092770

Pubmed Central ID:

PMC4197864

Description:

In this report, we describe the development of a modified adeno-associated virus (AAV) capsid and promoter for transduction of retinal ON-bipolar cells. The bipolar cells, which are post-synaptic to the photoreceptors, are important retinal targets for both basic and preclinical research. In particular, a therapeutic strategy under investigation for advanced forms of blindness involves using optogenetic molecules to render ON-bipolar cells light-sensitive. Currently, delivery of adequate levels of gene expression is a limiting step for this approach. The synthetic AAV capsid and promoter described here achieves high level of optogenetic transgene expression in ON-bipolar cells. This evokes high-frequency (~100 Hz) spiking responses in ganglion cells of previously blind, rd1, mice. Our vector is a promising vehicle for further development toward potential clinical use.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

1R24EY019861‐01A1/EY/NEI NIH HHS/United States
8DP1 EY023177/DP/NCCDPHP CDC HHS/United States
DP1 EY023177/EY/NEI NIH HHS/United States
DP1 OD008267/OD/NIH HHS/United States
R24 EY019861/EY/NEI NIH HHS/United States

Supporting Files:

	emmm0006-1175-f1.gif	image/gif
	emmm0006-1175-f1.jpg	image/jpeg
	emmm0006-1175-f2.gif	image/gif
	emmm0006-1175-f2.jpg	image/jpeg
	emmm0006-1175-f3.gif	image/gif
	emmm0006-1175-f3.jpg	image/jpeg
	emmm0006-1175-f4.gif	image/gif
	emmm0006-1175-f4.jpg	image/jpeg

No Related Documents.

You May Also Like:

Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials

Personal Author:

Minella, AL; Mowat, FM; Willett, KL; Sledge, D; Bartoe, JT; Bennett, J; Petersen-Jones, SM;

Published:

Jul 24 2014

Source:

Gene Ther. 2014; 21(10):913-920.

Description:

The cat is emerging as a promising large animal model for preclinical testing of retinal dystrophy therapies, for example, by gene therapy. However, there is a paucity of studies investigating viral vector gene transfer to the feline retina. We there...

File Type:

[PDF - 2.09 MB]
Optical Control of Mammalian Endogenous Transcription and Epigenetic States

Personal Author:

Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro; Hsu, Patrick D.; Heidenreich, Matthias; Cong, Le; Platt, Randall J.; Scott, David A.; Church, George M.; Zhang, Feng;

Published:

Aug 23 2013

Source:

Nature. 500(7463):472-476.

Description:

The dynamic nature of gene expression enables cellular programming, homeostasis and environmental adaptation in living systems. Dissection of causal gene functions in cellular and organismal processes therefore necessitates approaches that enable spa...

File Type:

[PDF - 1.06 MB]
In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector

Personal Author:

Zinn, Eric; Pacouret, Simon; Khaychuk, Vadim; Turunen, Heikki T.; Carvalho, Livia S.; Andres-Mateos, Eva; Shah, Samiksha; Shelke, Rajani; Maurer, Anna C.; Plovie, Eva; Xiao, Ru; Vandenberghe, Luk H.;

Published:

Jul 30 2015

Source:

Cell Rep. 12(6):1056-1068.

Description:

Adeno-associated virus (AAV) vectors have emerged as a gene-delivery platform with demonstrated safety and efficacy in a handful of clinical trials for monogenic disorders. However, limitations of the current generation vectors often prevent broader ...

File Type:

[PDF - 2.53 MB]
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

Personal Author:

Deverman, Benjamin E.; Pravdo, Piers L.; Simpson, Bryan P.; Kumar, Sripriya Ravindra; Chan, Ken Y.; Banerjee, Abhik; Wu, Wei-Li; Yang, Bin; Huber, Nina; Pasca, Sergiu P.; Gradinaru, Viviana;

Published:

Feb 1 2016

Source:

Nat Biotechnol. 34(2):204-209.

Description:

Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in vivo gene transfer. However, the tropism repertoire of naturally occurring AAVs is limited, prompting a search for novel AAV capsids with desired characteristics. Here we ...

File Type:

[PDF - 2.06 MB]
Noninvasive optical inhibition with a red-shifted microbial rhodopsin

Personal Author:

Chuong, Amy S; Miri, Mitra L; Busskamp, Volker; Matthews, Gillian A C; Acker, Leah C; Sørensen, Andreas T; Young, Andrew; Klapoetke, Nathan C; Henninger, Mike A; Kodandaramaiah, Suhasa B; Ogawa, Masaaki; Ramanlal, Shreshtha B; Bandler, Rachel C; Allen, Brian D; Forest, Craig R; Chow, Brian Y; Han, Xue; Lin, Yingxi; Tye, Kay M; Roska, Botond; Cardin, Jessica A; Boyden, Edward S;

Published:

Jul 06 2014

Source:

Nat Neurosci. 17(8):1123-1129.

Description:

Optogenetic inhibition of the electrical activity of neurons enables the causal assessment of their contributions to brain functions. Red light penetrates deeper into tissue than other visible wavelengths. We present a red-shifted cruxhalorhodopsin, ...

File Type:

[PDF - 1.73 MB]